APASL 2017: 2 月 19 日大会日程
Auditorium
08:30 – 09:00 State-of the Art 10
09:00 – 09:30 State-of the Art 13
11:45 - 13:30 Concurrent Session 15: Trend and Challenges of HCC in Asia
13:45 - 15:15 Plenary Presentation 03
15:30 - 16:00 Closing Ceremony
Grand Ballroom II
08:30 – 09:00 State-of the Art 11
09:00 – 09:30 State-of the Art 14
10:00 - 11:45 Concurrent Session 13: Viral Hepatitis and Co-Infection
13:45 - 15:15 Young Investigator Presentation 03
Grand Ballroom III
08:30 – 09:00 State-of the Art 12
09:00 – 09:30 State-of the Art 15
10:00 - 11:30 Concurrent Session 14: Globalization of Fatty Liver: NAFLD in Asia Pacific Region
Yellow River Hall
10:00 – 11:30 Translational Medicine Course 05:Liver Cancer - HCC Signaling
11:45 – 13:15 Translational Medicine Course 06:HBV - Concept and Development of Direct Acting Agents (DAAs)
13:30 – 15:00 Translational Medicine Course 07:HBV - Concept and Development of Host Targeting Agents (HTAs)
5B
10:00 – 11:30 Oral Presentation 25: Viral Hepatitis B and D - Treatment 3
5C
10:00 – 11:30 Oral Presentation 26: Viral Hepatitis B and D - Virology,Immunology and Pathogenesis 3
5B+5C
11:45 – 13:30 Special Netowrk Group 09: Animal Models
5D
10:00 – 11:30 Oral Presentation 27: Viral Hepatitis C - Therapeutics: New Agents (not approved) 2
5E
10:00 – 11:30 Oral Presentation 28: Viral Hepatitis C - Therapeutics (approved agents) 3
5D+5E
13:30 – 15:00 Special Netowrk Group 10: Cutting Edge in Evaluation of Liver Fibrosis: Invasive or Noninvasive
5F
10:00 – 11:30 Oral Presentation 29: Cirrhosis and Its Complications
5H
10:00 – 11:30 Oral Presentation 30: Alcoholic Liver Disease and NASH
5I
10:00 – 11:30 Oral Presentation 31: Liver Cancer - Diagnosis and Prognosis 2
5J
10:00 – 11:30 Oral Presentation 32: Genetic and Paediatric Liver Diseases
Yangtze River Hall
09:30 – 15:00 Poster Session
Mandarin + Century Hall
09:30 – 10:00 Coffee Break
12:00 – 13:30 Lunch Break
关注感染时间 回复「绑定」获取 5 丁当